Loading clinical trials...
Loading clinical trials...
The primary objective of the study is to validate the safety and clinical performance of the ABLE Exoskeleton device in people with acquired brain injury during a 10-session gait training program in a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
ABLE Human Motion S.L.
Collaborators
NCT06749197 · Acquired Brain Injury (Including Stroke)
NCT06774287 · Acquired Brain Injury (Including Stroke)
NCT06800040 · Acquired Brain Injury (Including Stroke)
NCT07065916 · Hemiplegia, Cerebral Palsy Spastic Hemiplegic, and more
NCT06952595 · Acquired Brain Injury (Including Stroke)
Cefine Neurología (CEFINE)
Culleredo, A Coruña
Fundación Step by Step
L'Hospitalet de Llobregat, Barcelona
Centro Europeo de Neurociencias (CEN)
Madrid, Madrid
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions